Clinical and Medication Outcome After Short-term Alprazolam and Behavorial Group Treatment in Panic Disorder
Authors:
- John H. KrystalJKJohn H. Krystal
- Scott W. WoodsSWScott W. Woods
- Dennis S. CharneyDCDennis S. Charney
- 1 November 1989
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of General Psychiatry
- Vol. 46 (11) , 993-999
Abstract
From JAMA Psychiatry — Clinical and Medication Outcome After Short-term Alprazolam and Behavorial Group Treatment in Panic Disorder — 2.5-Year Naturalistic Follow-up StudyKeywords
This publication has 28 references indexed in Scilit:
- Discontinuation of alprazolam treatment in panic patientsAmerican Journal of Psychiatry, 1987
- Two-year follow-up of exposure and imipramine treatment of agoraphobiaAmerican Journal of Psychiatry, 1986
- Some Biochemical Correlates of Panic Attacks with Agoraphobia and Their Response to a New TreatmentJournal of Clinical Psychopharmacology, 1984
- Antipanic effect of clonazepamAmerican Journal of Psychiatry, 1984
- Changes in the Drug Treatment of Anxiety DisordersPsychopathology, 1984
- Alprazolam in the treatment of generalized anxiety and panic disorders: A double-blind placebo-controlled studyPsychopharmacology, 1982
- Treatment of Agoraphobia With Group Exposure In Vivo and ImipramineArchives of General Psychiatry, 1980
- Behavior Therapy, Supportive Psychotherapy, Imipramine, and PhobiasArchives of General Psychiatry, 1978
- Symptomatic Treatment of Agoraphobia and Social Phobias: A Follow-up StudyThe British Journal of Psychiatry, 1975
- Behaviour Therapy versus Drug Therapy in the Treatment of Phobic NeurosisCanadian Psychiatric Association Journal, 1973